Looking at MS Differently - Consider B and T cell crosstalk in the complex dynamics of immune response

It’s time to look at MS differently

The science of multiple sclerosis (MS) is still under construction—there’s much more to know. Join us at GetCloserToMS.com to learn more about what may hold the next big advancement.

The science of MS is under construction

Explore the key players in MS that drive and perpetuate neuroinflammation1-4

B and T cell crosstalk in MS

Consider B and T cell crosstalk in the complex dynamics of immune response3

References: 1. Salou M, Nicol B, Garcia A, Laplaud DA. Involvement of CD8+ T cells in multiple sclerosis. Front Immunol. 2015;6:604. 2. Bittner S, Ruck T, Wiendl H, Grauer OM, Meuth SG. Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management. Ther Adv Neurol Disord. 2017;10(1):51-66. 3. Baker D, Marta M, Pryce G, Giovannoni G, Schmierer K. Memory B cells are major targets for effective immunotherapy in relapsing multiple sclerosis. EBioMedicine. 2017;16:41-50. 4. Li R, Rezk A, Healy LM, et al. Cytokine-defined B cell responses as therapeutic targets in multiple sclerosis. Front Immunol. 2015;6:626.

----------------------------------------------------                      

Article Provided by:  #MSViewsandNews

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::